Cargando…
miR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT
Acquired chemo-resistance is one of the key causal factors in cancer death. Emerging evidences suggest that miRNA and epithelial–mesenchymal transition play critical roles in the chemo-resistance in cancers. Here, we showed the association of paclitaxel-resistance with miR-375 over-expression and ep...
Autores principales: | Shen, Yuanming, Zhou, Jiansong, Li, Yang, Ye, Feng, Wan, Xiaoyun, Lu, Weiguo, Xie, Xing, Cheng, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199595/ https://www.ncbi.nlm.nih.gov/pubmed/25330011 http://dx.doi.org/10.1371/journal.pone.0109299 |
Ejemplares similares
-
miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
por: Shen, Y, et al.
Publicado: (2013) -
miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT
por: Wang, Bin, et al.
Publicado: (2016) -
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
por: Xue, Hui-Ying, et al.
Publicado: (2016) -
Expression and prognostic significance of miR-375 and miR-221 in liver cancer
por: Xie, Dafei, et al.
Publicado: (2017) -
MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
por: Fan, Yin-Ping, et al.
Publicado: (2017)